Clinical Trials Logo
  1. Home
  2. Chronic Bronchitis
  3. NCT00932802

Greatest International Antiinfective Trial With Avelox — GIANT  

Bronchitis, Chronic Clinical Trial

Official title:
GIANT - Greatest International Antiinfective Trial With Avelox®

Clinical Trial Summary

The observation period for each patient covered an initial treatment period with Avelox® plus optional 2 long-term follow-up periods (6 and 12 months).For each patient, the physician documented data at any initial visit (baseline) and at least one short-term follow-up visit (=initial treatment period).Optionally, long-term follow-ups (6 and 12 months) were documented, and a patient questionnaire was filled in.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00932802
Study type Observational
Source Bayer
Contact
Status Completed
Phase N/A
Start date February 2004
Completion date November 2007
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT00245453 - Outpatient Registry Trial of Respiratory Tract Infections in Adults Phase 4
Completed NCT00473460 - Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis Phase 3
Completed NCT00649831 - A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis Phase 3
Completed NCT01507415 - Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD? N/A
Active, not recruiting NCT00608764 - Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Completed NCT00538148 - Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD Phase 4
Completed NCT02637219 - Innate Immune Response in COPD N/A
Completed NCT00406705 - The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPD Phase 2
Completed NCT00257140 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria Phase 2/Phase 3
Completed NCT01719822 - Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease N/A
Terminated NCT02261350 - Post-hospitalisation Nutritional Support and Gait Speed in COPD Phase 3
Completed NCT01495780 - eRT Remote Health Monitoring N/A
Completed NCT01077102 - Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD) N/A
Terminated NCT00288223 - Telithromycin in Acute Exacerbation of Chronic Bronchitis Phase 4
Completed NCT00644449 - A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis Phase 3
Completed NCT00423137 - Effect of BIBW 2948 BS in COPD Phase 2
Completed NCT02483637 - Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients N/A
Completed NCT00245427 - Outcomes of Patients Not Responding to Antibiotics in the Community N/A
Completed NCT00035828 - A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD Phase 2
Completed NCT00184977 - COPD on Primary Care Treatment (COOPT) Phase 4